Lindbrook Capital’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-14
| Closed | -$132 | – | 2930 |
|
2024
Q4 | $132 | Buy |
+14
| New | +$132 | ﹤0.01% | 2732 |
|
2024
Q3 | – | Sell |
-53
| Closed | -$449 | – | 2910 |
|
2024
Q2 | $449 | Buy |
+53
| New | +$449 | ﹤0.01% | 2647 |
|
2024
Q1 | – | Sell |
-280
| Closed | -$3.15K | – | 2759 |
|
2023
Q4 | $3.15K | Buy |
+280
| New | +$3.15K | ﹤0.01% | 2095 |
|
2023
Q1 | – | Sell |
-132
| Closed | -$1.48K | – | 2928 |
|
2022
Q4 | $1.48K | Buy |
132
+99
| +300% | +$1.11K | ﹤0.01% | 2359 |
|
2022
Q3 | $0 | Buy |
33
+7
| +27% | – | ﹤0.01% | 2920 |
|
2022
Q2 | $0 | Sell |
26
-567
| -96% | – | ﹤0.01% | 2787 |
|
2022
Q1 | $6K | Buy |
+593
| New | +$6K | ﹤0.01% | 1547 |
|
2020
Q3 | – | Sell |
-43
| Closed | -$1K | – | 1837 |
|
2020
Q2 | $1K | Hold |
43
| – | – | ﹤0.01% | 1633 |
|
2020
Q1 | $1K | Buy |
+43
| New | +$1K | ﹤0.01% | 1561 |
|